Both in Biotechnology
Replimune Group vs Novavax
Over the past year REPL returned +130.7% and NVAX returned +41.8%; their daily moves had a correlation of 0.12.
REPL +130.7% NVAX +41.8%Growth of $1, one year, split-adjusted
| Metric | REPL | NVAX |
|---|---|---|
| Price | $20.69 | $10.65 |
| Market cap | $1.96B | $1.76B |
| Today | +0.19% | +10.02% |
| 1 month | +56.2% | −5.9% |
| 6 months | +501.5% | +13.8% |
| Year to date | +112.9% | +58.5% |
| 1 year | — | +34.6% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | — | 74.9% |
| Net margin | — | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.2× |
| Net cash | $183.7M | $422.0M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 82.7% |
| Short % of float | 29.6% | 30.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).